Predictive Value of Pretreatment BCR-ABL(IS) Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML)

por El-Metnawy, Wafaa H., Mattar, Mervat M., El-Nahass, Yasser H., Samra, Mohamed A., Abdelhamid, Hala M., AbdlFattah, Raafat M., Hamed, Ahmad R.
Publicado 2013

IDH Mutations in AML Patients; A higher Association with Intermediate Risk Cytogenetics

por ElNahass, Yasser H, Badawy, Ragia H, ElRefaey, Fatma A, Nooh, Hend A, Ibrahim, Dalia, Nader, Heba A, Mahmoud, Hossam K, ElMetnawy, Wafaa H
Publicado 2020

High Frequency of ASXL1 and IDH Mutations in Young Acute Myeloid Leukemia Egyptian Patients

por El Nahass, Yasser H, Nader, Heba A, Sabet, Salwa, Nooh, Hend A, Bassiony, Heba, Kamel, Mahmoud, Samra, Mohamed A, Mahmoud, Hossam K, El Metnawy, Wafaa H, El Refaey, Fatma A
Publicado 2022